Morgan Stanley Maintains Overweight on Labcorp Holdings, Raises Price Target to $338

Benzinga Newsdesk www.benzinga.com Positive 62.4%

Neg 0% Neu 0% Pos 62.4%

Morgan Stanley analyst Ricky Goldwasser maintains Labcorp Holdings (NYSE:LH) with a Overweight and raises the price target from $308 to $338.